Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period.
The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biologics and Biosimilars. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biologics and Biosimilars market.
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin, interferon, and monoclonal antibody (mAb) products.
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original 'innovator' products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
Global key biologics and biosimilars manufacturers include Johnson & Johnson, Pfizer, Roche, Amgen, AbbVie, and others. The top five manufacturers together account for approximately 50% of the market share, with the largest manufacturer being Pfizer with over 20% share. In terms of product categories, monoclonal antibodies are the largest segment with a market share of 43%, followed by vaccines with a 30% share. In terms of applications, hospitals are the top application area, with about 85% of the market share.
Key Features:
The report on Biologics and Biosimilars market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biologics and Biosimilars market. It may include historical data, market segmentation by Type (e.g., Monoclonal Antibodies, Interferon), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biologics and Biosimilars market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biologics and Biosimilars market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biologics and Biosimilars industry. This include advancements in Biologics and Biosimilars technology, Biologics and Biosimilars new entrants, Biologics and Biosimilars new investment, and other innovations that are shaping the future of Biologics and Biosimilars.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biologics and Biosimilars market. It includes factors influencing customer ' purchasing decisions, preferences for Biologics and Biosimilars product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biologics and Biosimilars market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biologics and Biosimilars market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biologics and Biosimilars market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biologics and Biosimilars industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biologics and Biosimilars market.
Market Segmentation:
Biologics and Biosimilars market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period.
The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biologics and Biosimilars. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biologics and Biosimilars market.
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin, interferon, and monoclonal antibody (mAb) products.
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original 'innovator' products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
Global key biologics and biosimilars manufacturers include Johnson & Johnson, Pfizer, Roche, Amgen, AbbVie, and others. The top five manufacturers together account for approximately 50% of the market share, with the largest manufacturer being Pfizer with over 20% share. In terms of product categories, monoclonal antibodies are the largest segment with a market share of 43%, followed by vaccines with a 30% share. In terms of applications, hospitals are the top application area, with about 85% of the market share.
Key Features:
The report on Biologics and Biosimilars market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biologics and Biosimilars market. It may include historical data, market segmentation by Type (e.g., Monoclonal Antibodies, Interferon), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biologics and Biosimilars market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biologics and Biosimilars market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biologics and Biosimilars industry. This include advancements in Biologics and Biosimilars technology, Biologics and Biosimilars new entrants, Biologics and Biosimilars new investment, and other innovations that are shaping the future of Biologics and Biosimilars.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biologics and Biosimilars market. It includes factors influencing customer ' purchasing decisions, preferences for Biologics and Biosimilars product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biologics and Biosimilars market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biologics and Biosimilars market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biologics and Biosimilars market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biologics and Biosimilars industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biologics and Biosimilars market.
Market Segmentation:
Biologics and Biosimilars market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Monoclonal Antibodies
- Interferon
- Insulin
- Vaccines
- Others
- Hospital
- Retail Pharmacy
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Amgen
- AbbVie
- Sanofi
- Johnson & Johnson
- Pfizer
- Novo Nordisk
- Eli Lilly
- Novartis
- Merck
- Biogen
- Celltrion
- Sobi
- 3SBIO
- Changchun High Tech
- Kanghong Pharma
- Innovent Biologics
- Gan&Lee
- Tonghua Dongbao
- United Laboratory
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biologics and Biosimilars Market Size 2019-2030
2.1.2 Biologics and Biosimilars Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Biologics and Biosimilars Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Interferon
2.2.3 Insulin
2.2.4 Vaccines
2.2.5 Others
2.3 Biologics and Biosimilars Market Size by Type
2.3.1 Biologics and Biosimilars Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biologics and Biosimilars Market Size Market Share by Type (2019-2024)
2.4 Biologics and Biosimilars Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Other
2.5 Biologics and Biosimilars Market Size by Application
2.5.1 Biologics and Biosimilars Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biologics and Biosimilars Market Size Market Share by Application (2019-2024)
3 BIOLOGICS AND BIOSIMILARS MARKET SIZE BY PLAYER
3.1 Biologics and Biosimilars Market Size Market Share by Players
3.1.1 Global Biologics and Biosimilars Revenue by Players (2019-2024)
3.1.2 Global Biologics and Biosimilars Revenue Market Share by Players (2019-2024)
3.2 Global Biologics and Biosimilars Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOLOGICS AND BIOSIMILARS BY REGIONS
4.1 Biologics and Biosimilars Market Size by Regions (2019-2024)
4.2 Americas Biologics and Biosimilars Market Size Growth (2019-2024)
4.3 APAC Biologics and Biosimilars Market Size Growth (2019-2024)
4.4 Europe Biologics and Biosimilars Market Size Growth (2019-2024)
4.5 Middle East & Africa Biologics and Biosimilars Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Biologics and Biosimilars Market Size by Country (2019-2024)
5.2 Americas Biologics and Biosimilars Market Size by Type (2019-2024)
5.3 Americas Biologics and Biosimilars Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologics and Biosimilars Market Size by Region (2019-2024)
6.2 APAC Biologics and Biosimilars Market Size by Type (2019-2024)
6.3 APAC Biologics and Biosimilars Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biologics and Biosimilars by Country (2019-2024)
7.2 Europe Biologics and Biosimilars Market Size by Type (2019-2024)
7.3 Europe Biologics and Biosimilars Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biologics and Biosimilars by Region (2019-2024)
8.2 Middle East & Africa Biologics and Biosimilars Market Size by Type (2019-2024)
8.3 Middle East & Africa Biologics and Biosimilars Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOLOGICS AND BIOSIMILARS MARKET FORECAST
10.1 Global Biologics and Biosimilars Forecast by Regions (2025-2030)
10.1.1 Global Biologics and Biosimilars Forecast by Regions (2025-2030)
10.1.2 Americas Biologics and Biosimilars Forecast
10.1.3 APAC Biologics and Biosimilars Forecast
10.1.4 Europe Biologics and Biosimilars Forecast
10.1.5 Middle East & Africa Biologics and Biosimilars Forecast
10.2 Americas Biologics and Biosimilars Forecast by Country (2025-2030)
10.2.1 United States Biologics and Biosimilars Market Forecast
10.2.2 Canada Biologics and Biosimilars Market Forecast
10.2.3 Mexico Biologics and Biosimilars Market Forecast
10.2.4 Brazil Biologics and Biosimilars Market Forecast
10.3 APAC Biologics and Biosimilars Forecast by Region (2025-2030)
10.3.1 China Biologics and Biosimilars Market Forecast
10.3.2 Japan Biologics and Biosimilars Market Forecast
10.3.3 Korea Biologics and Biosimilars Market Forecast
10.3.4 Southeast Asia Biologics and Biosimilars Market Forecast
10.3.5 India Biologics and Biosimilars Market Forecast
10.3.6 Australia Biologics and Biosimilars Market Forecast
10.4 Europe Biologics and Biosimilars Forecast by Country (2025-2030)
10.4.1 Germany Biologics and Biosimilars Market Forecast
10.4.2 France Biologics and Biosimilars Market Forecast
10.4.3 UK Biologics and Biosimilars Market Forecast
10.4.4 Italy Biologics and Biosimilars Market Forecast
10.4.5 Russia Biologics and Biosimilars Market Forecast
10.5 Middle East & Africa Biologics and Biosimilars Forecast by Region (2025-2030)
10.5.1 Egypt Biologics and Biosimilars Market Forecast
10.5.2 South Africa Biologics and Biosimilars Market Forecast
10.5.3 Israel Biologics and Biosimilars Market Forecast
10.5.4 Turkey Biologics and Biosimilars Market Forecast
10.5.5 GCC Countries Biologics and Biosimilars Market Forecast
10.6 Global Biologics and Biosimilars Forecast by Type (2025-2030)
10.7 Global Biologics and Biosimilars Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Biologics and Biosimilars Product Offered
11.1.3 Roche Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Biologics and Biosimilars Product Offered
11.2.3 Amgen Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Amgen Main Business Overview
11.2.5 Amgen Latest Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Biologics and Biosimilars Product Offered
11.3.3 AbbVie Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 AbbVie Main Business Overview
11.3.5 AbbVie Latest Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Biologics and Biosimilars Product Offered
11.4.3 Sanofi Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Sanofi Main Business Overview
11.4.5 Sanofi Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Biologics and Biosimilars Product Offered
11.5.3 Johnson & Johnson Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Biologics and Biosimilars Product Offered
11.6.3 Pfizer Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Information
11.7.2 Novo Nordisk Biologics and Biosimilars Product Offered
11.7.3 Novo Nordisk Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Novo Nordisk Main Business Overview
11.7.5 Novo Nordisk Latest Developments
11.8 Eli Lilly
11.8.1 Eli Lilly Company Information
11.8.2 Eli Lilly Biologics and Biosimilars Product Offered
11.8.3 Eli Lilly Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Eli Lilly Main Business Overview
11.8.5 Eli Lilly Latest Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Biologics and Biosimilars Product Offered
11.9.3 Novartis Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Novartis Main Business Overview
11.9.5 Novartis Latest Developments
11.10 Merck
11.10.1 Merck Company Information
11.10.2 Merck Biologics and Biosimilars Product Offered
11.10.3 Merck Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Merck Main Business Overview
11.10.5 Merck Latest Developments
11.11 Biogen
11.11.1 Biogen Company Information
11.11.2 Biogen Biologics and Biosimilars Product Offered
11.11.3 Biogen Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Biogen Main Business Overview
11.11.5 Biogen Latest Developments
11.12 Celltrion
11.12.1 Celltrion Company Information
11.12.2 Celltrion Biologics and Biosimilars Product Offered
11.12.3 Celltrion Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Celltrion Main Business Overview
11.12.5 Celltrion Latest Developments
11.13 Sobi
11.13.1 Sobi Company Information
11.13.2 Sobi Biologics and Biosimilars Product Offered
11.13.3 Sobi Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Sobi Main Business Overview
11.13.5 Sobi Latest Developments
11.14 3SBIO
11.14.1 3SBIO Company Information
11.14.2 3SBIO Biologics and Biosimilars Product Offered
11.14.3 3SBIO Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 3SBIO Main Business Overview
11.14.5 3SBIO Latest Developments
11.15 Changchun High Tech
11.15.1 Changchun High Tech Company Information
11.15.2 Changchun High Tech Biologics and Biosimilars Product Offered
11.15.3 Changchun High Tech Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Changchun High Tech Main Business Overview
11.15.5 Changchun High Tech Latest Developments
11.16 Kanghong Pharma
11.16.1 Kanghong Pharma Company Information
11.16.2 Kanghong Pharma Biologics and Biosimilars Product Offered
11.16.3 Kanghong Pharma Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Kanghong Pharma Main Business Overview
11.16.5 Kanghong Pharma Latest Developments
11.17 Innovent Biologics
11.17.1 Innovent Biologics Company Information
11.17.2 Innovent Biologics Biologics and Biosimilars Product Offered
11.17.3 Innovent Biologics Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Innovent Biologics Main Business Overview
11.17.5 Innovent Biologics Latest Developments
11.18 Gan&Lee
11.18.1 Gan&Lee Company Information
11.18.2 Gan&Lee Biologics and Biosimilars Product Offered
11.18.3 Gan&Lee Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Gan&Lee Main Business Overview
11.18.5 Gan&Lee Latest Developments
11.19 Tonghua Dongbao
11.19.1 Tonghua Dongbao Company Information
11.19.2 Tonghua Dongbao Biologics and Biosimilars Product Offered
11.19.3 Tonghua Dongbao Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Tonghua Dongbao Main Business Overview
11.19.5 Tonghua Dongbao Latest Developments
11.20 United Laboratory
11.20.1 United Laboratory Company Information
11.20.2 United Laboratory Biologics and Biosimilars Product Offered
11.20.3 United Laboratory Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 United Laboratory Main Business Overview
11.20.5 United Laboratory Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biologics and Biosimilars Market Size 2019-2030
2.1.2 Biologics and Biosimilars Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Biologics and Biosimilars Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Interferon
2.2.3 Insulin
2.2.4 Vaccines
2.2.5 Others
2.3 Biologics and Biosimilars Market Size by Type
2.3.1 Biologics and Biosimilars Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biologics and Biosimilars Market Size Market Share by Type (2019-2024)
2.4 Biologics and Biosimilars Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Other
2.5 Biologics and Biosimilars Market Size by Application
2.5.1 Biologics and Biosimilars Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biologics and Biosimilars Market Size Market Share by Application (2019-2024)
3 BIOLOGICS AND BIOSIMILARS MARKET SIZE BY PLAYER
3.1 Biologics and Biosimilars Market Size Market Share by Players
3.1.1 Global Biologics and Biosimilars Revenue by Players (2019-2024)
3.1.2 Global Biologics and Biosimilars Revenue Market Share by Players (2019-2024)
3.2 Global Biologics and Biosimilars Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOLOGICS AND BIOSIMILARS BY REGIONS
4.1 Biologics and Biosimilars Market Size by Regions (2019-2024)
4.2 Americas Biologics and Biosimilars Market Size Growth (2019-2024)
4.3 APAC Biologics and Biosimilars Market Size Growth (2019-2024)
4.4 Europe Biologics and Biosimilars Market Size Growth (2019-2024)
4.5 Middle East & Africa Biologics and Biosimilars Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Biologics and Biosimilars Market Size by Country (2019-2024)
5.2 Americas Biologics and Biosimilars Market Size by Type (2019-2024)
5.3 Americas Biologics and Biosimilars Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologics and Biosimilars Market Size by Region (2019-2024)
6.2 APAC Biologics and Biosimilars Market Size by Type (2019-2024)
6.3 APAC Biologics and Biosimilars Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biologics and Biosimilars by Country (2019-2024)
7.2 Europe Biologics and Biosimilars Market Size by Type (2019-2024)
7.3 Europe Biologics and Biosimilars Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biologics and Biosimilars by Region (2019-2024)
8.2 Middle East & Africa Biologics and Biosimilars Market Size by Type (2019-2024)
8.3 Middle East & Africa Biologics and Biosimilars Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOLOGICS AND BIOSIMILARS MARKET FORECAST
10.1 Global Biologics and Biosimilars Forecast by Regions (2025-2030)
10.1.1 Global Biologics and Biosimilars Forecast by Regions (2025-2030)
10.1.2 Americas Biologics and Biosimilars Forecast
10.1.3 APAC Biologics and Biosimilars Forecast
10.1.4 Europe Biologics and Biosimilars Forecast
10.1.5 Middle East & Africa Biologics and Biosimilars Forecast
10.2 Americas Biologics and Biosimilars Forecast by Country (2025-2030)
10.2.1 United States Biologics and Biosimilars Market Forecast
10.2.2 Canada Biologics and Biosimilars Market Forecast
10.2.3 Mexico Biologics and Biosimilars Market Forecast
10.2.4 Brazil Biologics and Biosimilars Market Forecast
10.3 APAC Biologics and Biosimilars Forecast by Region (2025-2030)
10.3.1 China Biologics and Biosimilars Market Forecast
10.3.2 Japan Biologics and Biosimilars Market Forecast
10.3.3 Korea Biologics and Biosimilars Market Forecast
10.3.4 Southeast Asia Biologics and Biosimilars Market Forecast
10.3.5 India Biologics and Biosimilars Market Forecast
10.3.6 Australia Biologics and Biosimilars Market Forecast
10.4 Europe Biologics and Biosimilars Forecast by Country (2025-2030)
10.4.1 Germany Biologics and Biosimilars Market Forecast
10.4.2 France Biologics and Biosimilars Market Forecast
10.4.3 UK Biologics and Biosimilars Market Forecast
10.4.4 Italy Biologics and Biosimilars Market Forecast
10.4.5 Russia Biologics and Biosimilars Market Forecast
10.5 Middle East & Africa Biologics and Biosimilars Forecast by Region (2025-2030)
10.5.1 Egypt Biologics and Biosimilars Market Forecast
10.5.2 South Africa Biologics and Biosimilars Market Forecast
10.5.3 Israel Biologics and Biosimilars Market Forecast
10.5.4 Turkey Biologics and Biosimilars Market Forecast
10.5.5 GCC Countries Biologics and Biosimilars Market Forecast
10.6 Global Biologics and Biosimilars Forecast by Type (2025-2030)
10.7 Global Biologics and Biosimilars Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Biologics and Biosimilars Product Offered
11.1.3 Roche Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Biologics and Biosimilars Product Offered
11.2.3 Amgen Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Amgen Main Business Overview
11.2.5 Amgen Latest Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Biologics and Biosimilars Product Offered
11.3.3 AbbVie Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 AbbVie Main Business Overview
11.3.5 AbbVie Latest Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Biologics and Biosimilars Product Offered
11.4.3 Sanofi Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Sanofi Main Business Overview
11.4.5 Sanofi Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Biologics and Biosimilars Product Offered
11.5.3 Johnson & Johnson Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Biologics and Biosimilars Product Offered
11.6.3 Pfizer Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Information
11.7.2 Novo Nordisk Biologics and Biosimilars Product Offered
11.7.3 Novo Nordisk Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Novo Nordisk Main Business Overview
11.7.5 Novo Nordisk Latest Developments
11.8 Eli Lilly
11.8.1 Eli Lilly Company Information
11.8.2 Eli Lilly Biologics and Biosimilars Product Offered
11.8.3 Eli Lilly Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Eli Lilly Main Business Overview
11.8.5 Eli Lilly Latest Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Biologics and Biosimilars Product Offered
11.9.3 Novartis Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Novartis Main Business Overview
11.9.5 Novartis Latest Developments
11.10 Merck
11.10.1 Merck Company Information
11.10.2 Merck Biologics and Biosimilars Product Offered
11.10.3 Merck Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Merck Main Business Overview
11.10.5 Merck Latest Developments
11.11 Biogen
11.11.1 Biogen Company Information
11.11.2 Biogen Biologics and Biosimilars Product Offered
11.11.3 Biogen Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Biogen Main Business Overview
11.11.5 Biogen Latest Developments
11.12 Celltrion
11.12.1 Celltrion Company Information
11.12.2 Celltrion Biologics and Biosimilars Product Offered
11.12.3 Celltrion Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Celltrion Main Business Overview
11.12.5 Celltrion Latest Developments
11.13 Sobi
11.13.1 Sobi Company Information
11.13.2 Sobi Biologics and Biosimilars Product Offered
11.13.3 Sobi Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Sobi Main Business Overview
11.13.5 Sobi Latest Developments
11.14 3SBIO
11.14.1 3SBIO Company Information
11.14.2 3SBIO Biologics and Biosimilars Product Offered
11.14.3 3SBIO Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 3SBIO Main Business Overview
11.14.5 3SBIO Latest Developments
11.15 Changchun High Tech
11.15.1 Changchun High Tech Company Information
11.15.2 Changchun High Tech Biologics and Biosimilars Product Offered
11.15.3 Changchun High Tech Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Changchun High Tech Main Business Overview
11.15.5 Changchun High Tech Latest Developments
11.16 Kanghong Pharma
11.16.1 Kanghong Pharma Company Information
11.16.2 Kanghong Pharma Biologics and Biosimilars Product Offered
11.16.3 Kanghong Pharma Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Kanghong Pharma Main Business Overview
11.16.5 Kanghong Pharma Latest Developments
11.17 Innovent Biologics
11.17.1 Innovent Biologics Company Information
11.17.2 Innovent Biologics Biologics and Biosimilars Product Offered
11.17.3 Innovent Biologics Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Innovent Biologics Main Business Overview
11.17.5 Innovent Biologics Latest Developments
11.18 Gan&Lee
11.18.1 Gan&Lee Company Information
11.18.2 Gan&Lee Biologics and Biosimilars Product Offered
11.18.3 Gan&Lee Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Gan&Lee Main Business Overview
11.18.5 Gan&Lee Latest Developments
11.19 Tonghua Dongbao
11.19.1 Tonghua Dongbao Company Information
11.19.2 Tonghua Dongbao Biologics and Biosimilars Product Offered
11.19.3 Tonghua Dongbao Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Tonghua Dongbao Main Business Overview
11.19.5 Tonghua Dongbao Latest Developments
11.20 United Laboratory
11.20.1 United Laboratory Company Information
11.20.2 United Laboratory Biologics and Biosimilars Product Offered
11.20.3 United Laboratory Biologics and Biosimilars Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 United Laboratory Main Business Overview
11.20.5 United Laboratory Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biologics and Biosimilars Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Monoclonal Antibodies
Table 3. Major Players of Interferon
Table 4. Major Players of Insulin
Table 5. Major Players of Vaccines
Table 6. Major Players of Others
Table 7. Biologics and Biosimilars Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Biologics and Biosimilars Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Biologics and Biosimilars Market Size Market Share by Type (2019-2024)
Table 10. Biologics and Biosimilars Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Biologics and Biosimilars Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Biologics and Biosimilars Market Size Market Share by Application (2019-2024)
Table 13. Global Biologics and Biosimilars Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Biologics and Biosimilars Revenue Market Share by Player (2019-2024)
Table 15. Biologics and Biosimilars Key Players Head office and Products Offered
Table 16. Biologics and Biosimilars Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Biologics and Biosimilars Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Biologics and Biosimilars Market Size Market Share by Regions (2019-2024)
Table 21. Global Biologics and Biosimilars Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Biologics and Biosimilars Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Biologics and Biosimilars Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Biologics and Biosimilars Market Size Market Share by Country (2019-2024)
Table 25. Americas Biologics and Biosimilars Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Biologics and Biosimilars Market Size Market Share by Type (2019-2024)
Table 27. Americas Biologics and Biosimilars Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Biologics and Biosimilars Market Size Market Share by Application (2019-2024)
Table 29. APAC Biologics and Biosimilars Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Biologics and Biosimilars Market Size Market Share by Region (2019-2024)
Table 31. APAC Biologics and Biosimilars Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Biologics and Biosimilars Market Size Market Share by Type (2019-2024)
Table 33. APAC Biologics and Biosimilars Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Biologics and Biosimilars Market Size Market Share by Application (2019-2024)
Table 35. Europe Biologics and Biosimilars Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Biologics and Biosimilars Market Size Market Share by Country (2019-2024)
Table 37. Europe Biologics and Biosimilars Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Biologics and Biosimilars Market Size Market Share by Type (2019-2024)
Table 39. Europe Biologics and Biosimilars Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Biologics and Biosimilars Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Biologics and Biosimilars Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Biologics and Biosimilars Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Biologics and Biosimilars Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Biologics and Biosimilars Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Biologics and Biosimilars Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Biologics and Biosimilars Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Biologics and Biosimilars
Table 48. Key Market Challenges & Risks of Biologics and Biosimilars
Table 49. Key Industry Trends of Biologics and Biosimilars
Table 50. Global Biologics and Biosimilars Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Biologics and Biosimilars Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Biologics and Biosimilars Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Biologics and Biosimilars Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Roche Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 55. Roche Biologics and Biosimilars Product Offered
Table 56. Roche Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Roche Main Business
Table 58. Roche Latest Developments
Table 59. Amgen Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 60. Amgen Biologics and Biosimilars Product Offered
Table 61. Amgen Main Business
Table 62. Amgen Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Amgen Latest Developments
Table 64. AbbVie Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 65. AbbVie Biologics and Biosimilars Product Offered
Table 66. AbbVie Main Business
Table 67. AbbVie Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. AbbVie Latest Developments
Table 69. Sanofi Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 70. Sanofi Biologics and Biosimilars Product Offered
Table 71. Sanofi Main Business
Table 72. Sanofi Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Sanofi Latest Developments
Table 74. Johnson & Johnson Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 75. Johnson & Johnson Biologics and Biosimilars Product Offered
Table 76. Johnson & Johnson Main Business
Table 77. Johnson & Johnson Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Johnson & Johnson Latest Developments
Table 79. Pfizer Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 80. Pfizer Biologics and Biosimilars Product Offered
Table 81. Pfizer Main Business
Table 82. Pfizer Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Pfizer Latest Developments
Table 84. Novo Nordisk Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 85. Novo Nordisk Biologics and Biosimilars Product Offered
Table 86. Novo Nordisk Main Business
Table 87. Novo Nordisk Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Novo Nordisk Latest Developments
Table 89. Eli Lilly Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 90. Eli Lilly Biologics and Biosimilars Product Offered
Table 91. Eli Lilly Main Business
Table 92. Eli Lilly Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Eli Lilly Latest Developments
Table 94. Novartis Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 95. Novartis Biologics and Biosimilars Product Offered
Table 96. Novartis Main Business
Table 97. Novartis Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Novartis Latest Developments
Table 99. Merck Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 100. Merck Biologics and Biosimilars Product Offered
Table 101. Merck Main Business
Table 102. Merck Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Merck Latest Developments
Table 104. Biogen Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 105. Biogen Biologics and Biosimilars Product Offered
Table 106. Biogen Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. Biogen Main Business
Table 108. Biogen Latest Developments
Table 109. Celltrion Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 110. Celltrion Biologics and Biosimilars Product Offered
Table 111. Celltrion Main Business
Table 112. Celltrion Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Celltrion Latest Developments
Table 114. Sobi Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 115. Sobi Biologics and Biosimilars Product Offered
Table 116. Sobi Main Business
Table 117. Sobi Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Sobi Latest Developments
Table 119. 3SBIO Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 120. 3SBIO Biologics and Biosimilars Product Offered
Table 121. 3SBIO Main Business
Table 122. 3SBIO Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. 3SBIO Latest Developments
Table 124. Changchun High Tech Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 125. Changchun High Tech Biologics and Biosimilars Product Offered
Table 126. Changchun High Tech Main Business
Table 127. Changchun High Tech Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 128. Changchun High Tech Latest Developments
Table 129. Kanghong Pharma Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 130. Kanghong Pharma Biologics and Biosimilars Product Offered
Table 131. Kanghong Pharma Main Business
Table 132. Kanghong Pharma Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 133. Kanghong Pharma Latest Developments
Table 134. Innovent Biologics Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 135. Innovent Biologics Biologics and Biosimilars Product Offered
Table 136. Innovent Biologics Main Business
Table 137. Innovent Biologics Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 138. Innovent Biologics Latest Developments
Table 139. Gan&Lee Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 140. Gan&Lee Biologics and Biosimilars Product Offered
Table 141. Gan&Lee Main Business
Table 142. Gan&Lee Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 143. Gan&Lee Latest Developments
Table 144. Tonghua Dongbao Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 145. Tonghua Dongbao Biologics and Biosimilars Product Offered
Table 146. Tonghua Dongbao Main Business
Table 147. Tonghua Dongbao Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 148. Tonghua Dongbao Latest Developments
Table 149. United Laboratory Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 150. United Laboratory Biologics and Biosimilars Product Offered
Table 151. United Laboratory Main Business
Table 152. United Laboratory Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 153. United Laboratory Latest Developments
Table 1. Biologics and Biosimilars Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Monoclonal Antibodies
Table 3. Major Players of Interferon
Table 4. Major Players of Insulin
Table 5. Major Players of Vaccines
Table 6. Major Players of Others
Table 7. Biologics and Biosimilars Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Biologics and Biosimilars Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Biologics and Biosimilars Market Size Market Share by Type (2019-2024)
Table 10. Biologics and Biosimilars Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Biologics and Biosimilars Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Biologics and Biosimilars Market Size Market Share by Application (2019-2024)
Table 13. Global Biologics and Biosimilars Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Biologics and Biosimilars Revenue Market Share by Player (2019-2024)
Table 15. Biologics and Biosimilars Key Players Head office and Products Offered
Table 16. Biologics and Biosimilars Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Biologics and Biosimilars Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Biologics and Biosimilars Market Size Market Share by Regions (2019-2024)
Table 21. Global Biologics and Biosimilars Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Biologics and Biosimilars Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Biologics and Biosimilars Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Biologics and Biosimilars Market Size Market Share by Country (2019-2024)
Table 25. Americas Biologics and Biosimilars Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Biologics and Biosimilars Market Size Market Share by Type (2019-2024)
Table 27. Americas Biologics and Biosimilars Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Biologics and Biosimilars Market Size Market Share by Application (2019-2024)
Table 29. APAC Biologics and Biosimilars Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Biologics and Biosimilars Market Size Market Share by Region (2019-2024)
Table 31. APAC Biologics and Biosimilars Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Biologics and Biosimilars Market Size Market Share by Type (2019-2024)
Table 33. APAC Biologics and Biosimilars Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Biologics and Biosimilars Market Size Market Share by Application (2019-2024)
Table 35. Europe Biologics and Biosimilars Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Biologics and Biosimilars Market Size Market Share by Country (2019-2024)
Table 37. Europe Biologics and Biosimilars Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Biologics and Biosimilars Market Size Market Share by Type (2019-2024)
Table 39. Europe Biologics and Biosimilars Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Biologics and Biosimilars Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Biologics and Biosimilars Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Biologics and Biosimilars Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Biologics and Biosimilars Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Biologics and Biosimilars Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Biologics and Biosimilars Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Biologics and Biosimilars Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Biologics and Biosimilars
Table 48. Key Market Challenges & Risks of Biologics and Biosimilars
Table 49. Key Industry Trends of Biologics and Biosimilars
Table 50. Global Biologics and Biosimilars Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Biologics and Biosimilars Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Biologics and Biosimilars Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Biologics and Biosimilars Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Roche Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 55. Roche Biologics and Biosimilars Product Offered
Table 56. Roche Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Roche Main Business
Table 58. Roche Latest Developments
Table 59. Amgen Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 60. Amgen Biologics and Biosimilars Product Offered
Table 61. Amgen Main Business
Table 62. Amgen Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Amgen Latest Developments
Table 64. AbbVie Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 65. AbbVie Biologics and Biosimilars Product Offered
Table 66. AbbVie Main Business
Table 67. AbbVie Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. AbbVie Latest Developments
Table 69. Sanofi Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 70. Sanofi Biologics and Biosimilars Product Offered
Table 71. Sanofi Main Business
Table 72. Sanofi Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Sanofi Latest Developments
Table 74. Johnson & Johnson Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 75. Johnson & Johnson Biologics and Biosimilars Product Offered
Table 76. Johnson & Johnson Main Business
Table 77. Johnson & Johnson Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Johnson & Johnson Latest Developments
Table 79. Pfizer Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 80. Pfizer Biologics and Biosimilars Product Offered
Table 81. Pfizer Main Business
Table 82. Pfizer Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Pfizer Latest Developments
Table 84. Novo Nordisk Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 85. Novo Nordisk Biologics and Biosimilars Product Offered
Table 86. Novo Nordisk Main Business
Table 87. Novo Nordisk Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Novo Nordisk Latest Developments
Table 89. Eli Lilly Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 90. Eli Lilly Biologics and Biosimilars Product Offered
Table 91. Eli Lilly Main Business
Table 92. Eli Lilly Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Eli Lilly Latest Developments
Table 94. Novartis Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 95. Novartis Biologics and Biosimilars Product Offered
Table 96. Novartis Main Business
Table 97. Novartis Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Novartis Latest Developments
Table 99. Merck Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 100. Merck Biologics and Biosimilars Product Offered
Table 101. Merck Main Business
Table 102. Merck Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Merck Latest Developments
Table 104. Biogen Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 105. Biogen Biologics and Biosimilars Product Offered
Table 106. Biogen Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. Biogen Main Business
Table 108. Biogen Latest Developments
Table 109. Celltrion Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 110. Celltrion Biologics and Biosimilars Product Offered
Table 111. Celltrion Main Business
Table 112. Celltrion Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Celltrion Latest Developments
Table 114. Sobi Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 115. Sobi Biologics and Biosimilars Product Offered
Table 116. Sobi Main Business
Table 117. Sobi Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Sobi Latest Developments
Table 119. 3SBIO Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 120. 3SBIO Biologics and Biosimilars Product Offered
Table 121. 3SBIO Main Business
Table 122. 3SBIO Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. 3SBIO Latest Developments
Table 124. Changchun High Tech Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 125. Changchun High Tech Biologics and Biosimilars Product Offered
Table 126. Changchun High Tech Main Business
Table 127. Changchun High Tech Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 128. Changchun High Tech Latest Developments
Table 129. Kanghong Pharma Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 130. Kanghong Pharma Biologics and Biosimilars Product Offered
Table 131. Kanghong Pharma Main Business
Table 132. Kanghong Pharma Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 133. Kanghong Pharma Latest Developments
Table 134. Innovent Biologics Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 135. Innovent Biologics Biologics and Biosimilars Product Offered
Table 136. Innovent Biologics Main Business
Table 137. Innovent Biologics Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 138. Innovent Biologics Latest Developments
Table 139. Gan&Lee Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 140. Gan&Lee Biologics and Biosimilars Product Offered
Table 141. Gan&Lee Main Business
Table 142. Gan&Lee Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 143. Gan&Lee Latest Developments
Table 144. Tonghua Dongbao Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 145. Tonghua Dongbao Biologics and Biosimilars Product Offered
Table 146. Tonghua Dongbao Main Business
Table 147. Tonghua Dongbao Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 148. Tonghua Dongbao Latest Developments
Table 149. United Laboratory Details, Company Type, Biologics and Biosimilars Area Served and Its Competitors
Table 150. United Laboratory Biologics and Biosimilars Product Offered
Table 151. United Laboratory Main Business
Table 152. United Laboratory Biologics and Biosimilars Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 153. United Laboratory Latest Developments
LIST OF FIGURES
Figure 1. Biologics and Biosimilars Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biologics and Biosimilars Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Biologics and Biosimilars Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Biologics and Biosimilars Sales Market Share by Country/Region (2023)
Figure 8. Biologics and Biosimilars Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Biologics and Biosimilars Market Size Market Share by Type in 2023
Figure 10. Biologics and Biosimilars in Hospital
Figure 11. Global Biologics and Biosimilars Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Biologics and Biosimilars in Retail Pharmacy
Figure 13. Global Biologics and Biosimilars Market: Retail Pharmacy (2019-2024) & ($ Millions)
Figure 14. Biologics and Biosimilars in Other
Figure 15. Global Biologics and Biosimilars Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Biologics and Biosimilars Market Size Market Share by Application in 2023
Figure 17. Global Biologics and Biosimilars Revenue Market Share by Player in 2023
Figure 18. Global Biologics and Biosimilars Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Biologics and Biosimilars Market Size 2019-2024 ($ Millions)
Figure 20. APAC Biologics and Biosimilars Market Size 2019-2024 ($ Millions)
Figure 21. Europe Biologics and Biosimilars Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Biologics and Biosimilars Market Size 2019-2024 ($ Millions)
Figure 23. Americas Biologics and Biosimilars Value Market Share by Country in 2023
Figure 24. United States Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Biologics and Biosimilars Market Size Market Share by Region in 2023
Figure 29. APAC Biologics and Biosimilars Market Size Market Share by Type in 2023
Figure 30. APAC Biologics and Biosimilars Market Size Market Share by Application in 2023
Figure 31. China Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Biologics and Biosimilars Market Size Market Share by Country in 2023
Figure 38. Europe Biologics and Biosimilars Market Size Market Share by Type (2019-2024)
Figure 39. Europe Biologics and Biosimilars Market Size Market Share by Application (2019-2024)
Figure 40. Germany Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Biologics and Biosimilars Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Biologics and Biosimilars Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Biologics and Biosimilars Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 54. APAC Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 55. Europe Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 57. United States Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 58. Canada Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 61. China Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 62. Japan Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 63. Korea Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 65. India Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 66. Australia Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 67. Germany Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 68. France Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 69. UK Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 70. Italy Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 71. Russia Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 72. Spain Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 75. Israel Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 78. Global Biologics and Biosimilars Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Biologics and Biosimilars Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Biologics and Biosimilars Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biologics and Biosimilars Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Biologics and Biosimilars Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Biologics and Biosimilars Sales Market Share by Country/Region (2023)
Figure 8. Biologics and Biosimilars Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Biologics and Biosimilars Market Size Market Share by Type in 2023
Figure 10. Biologics and Biosimilars in Hospital
Figure 11. Global Biologics and Biosimilars Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Biologics and Biosimilars in Retail Pharmacy
Figure 13. Global Biologics and Biosimilars Market: Retail Pharmacy (2019-2024) & ($ Millions)
Figure 14. Biologics and Biosimilars in Other
Figure 15. Global Biologics and Biosimilars Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Biologics and Biosimilars Market Size Market Share by Application in 2023
Figure 17. Global Biologics and Biosimilars Revenue Market Share by Player in 2023
Figure 18. Global Biologics and Biosimilars Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Biologics and Biosimilars Market Size 2019-2024 ($ Millions)
Figure 20. APAC Biologics and Biosimilars Market Size 2019-2024 ($ Millions)
Figure 21. Europe Biologics and Biosimilars Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Biologics and Biosimilars Market Size 2019-2024 ($ Millions)
Figure 23. Americas Biologics and Biosimilars Value Market Share by Country in 2023
Figure 24. United States Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Biologics and Biosimilars Market Size Market Share by Region in 2023
Figure 29. APAC Biologics and Biosimilars Market Size Market Share by Type in 2023
Figure 30. APAC Biologics and Biosimilars Market Size Market Share by Application in 2023
Figure 31. China Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Biologics and Biosimilars Market Size Market Share by Country in 2023
Figure 38. Europe Biologics and Biosimilars Market Size Market Share by Type (2019-2024)
Figure 39. Europe Biologics and Biosimilars Market Size Market Share by Application (2019-2024)
Figure 40. Germany Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Biologics and Biosimilars Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Biologics and Biosimilars Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Biologics and Biosimilars Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Biologics and Biosimilars Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 54. APAC Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 55. Europe Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 57. United States Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 58. Canada Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 61. China Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 62. Japan Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 63. Korea Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 65. India Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 66. Australia Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 67. Germany Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 68. France Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 69. UK Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 70. Italy Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 71. Russia Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 72. Spain Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 75. Israel Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Biologics and Biosimilars Market Size 2025-2030 ($ Millions)
Figure 78. Global Biologics and Biosimilars Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Biologics and Biosimilars Market Size Market Share Forecast by Application (2025-2030)
